Alfred Lumsdaine
Known title: Chief Financial OfficerCIK: 0001188873
Alfred Lumsdaine's purchase track record
Alfred Lumsdaine has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/5/2026 | ARDT | $88K | +25.7% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ARDT | ▼ Sell | Tax Withholding | 3,389 | $36K | 9/25/2026 | View on chart |
| ARDT | ▲ Buy | Open Market | 10,000 | $88K | 6/5/2026 | View on chart |
| ARDT | ▼ Sell | Tax Withholding | 4,381 | $38K | 4/1/2026 | View on chart |
| ARDT | ▲ Buy | Grant | 53,846 | $0 | 4/1/2026 | View on chart |
| ARDT | ▼ Sell | Tax Withholding | 2,510 | $21K | 3/31/2026 | View on chart |
| ARDT | ▲ Buy | Grant | 61,081 | $0 | 3/11/2026 | View on chart |
| ARDT | ▼ Sell | Tax Withholding | 3,389 | $45K | 9/25/2025 | View on chart |
| ARDT | ▲ Buy | Grant | 53,971 | $0 | 4/1/2025 | View on chart |
| ARDT | ▼ Sell | Tax Withholding | 2,510 | $35K | 3/31/2025 | View on chart |
| ARDT | ▲ Buy | Grant | 41,742 | $0 | 9/25/2024 | View on chart |
| ARDT | ▲ Buy | Grant | 30,922 | $0 | 7/18/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ARDT Schedules Q3 2026 Results Call and Webcast
Ardent Health announced the date for its third quarter 2026 earnings conference call and webcast. The call will provide management’s discussion of the latest financial results and operational updates. Investors often use such events to assess performance trends, especially as the stock currently shows strong momentum on the chart.
ARDT Schedules Q3 2026 Results Call and Webcast. Ardent Health announced the date for its third quarter 2026 earnings conference call and webcast. The call will provide management’s discussion of the latest financial results and operational updates. Investors often use such events to assess performance trends, especially as the stock currently shows strong momentum on the chart.